365 related articles for article (PubMed ID: 17926096)
1. TRPV1 antagonists as potential antitussive agents.
McLeod RL; Correll CC; Jia Y; Anthes JC
Lung; 2008; 186 Suppl 1():S59-65. PubMed ID: 17926096
[TBL] [Abstract][Full Text] [Related]
2. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.
Khalid S; Murdoch R; Newlands A; Smart K; Kelsall A; Holt K; Dockry R; Woodcock A; Smith JA
J Allergy Clin Immunol; 2014 Jul; 134(1):56-62. PubMed ID: 24666696
[TBL] [Abstract][Full Text] [Related]
3. Antitussive effect of nociceptin/orphanin FQ in experimental cough models.
McLeod RL; Bolser DC; Jia Y; Parra LE; Mutter JC; Wang X; Tulshian DB; Egan RW; Hey JA
Pulm Pharmacol Ther; 2002; 15(3):213-6. PubMed ID: 12099766
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs.
Bhattacharya A; Scott BP; Nasser N; Ao H; Maher MP; Dubin AE; Swanson DM; Shankley NP; Wickenden AD; Chaplan SR
J Pharmacol Exp Ther; 2007 Nov; 323(2):665-74. PubMed ID: 17690251
[TBL] [Abstract][Full Text] [Related]
5. Regulating cough through modulation of sensory nerve function in the airways.
Spina D; Page CP
Pulm Pharmacol Ther; 2013 Oct; 26(5):486-90. PubMed ID: 23524012
[TBL] [Abstract][Full Text] [Related]
6. The research of the possible mechanism and the treatment for capsaicin-induced cough.
Zhang L; Sun T; Liu L; Wang L
Pulm Pharmacol Ther; 2018 Apr; 49():1-9. PubMed ID: 29288742
[TBL] [Abstract][Full Text] [Related]
7. Current and future prospects for drugs to suppress cough.
Chung KF
IDrugs; 2003 Aug; 6(8):781-6. PubMed ID: 12917774
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of cough.
Reynolds SM; Mackenzie AJ; Spina D; Page CP
Trends Pharmacol Sci; 2004 Nov; 25(11):569-76. PubMed ID: 15491779
[TBL] [Abstract][Full Text] [Related]
9. Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs.
Spina D; McFadzean I; Bertram FK; Page CP
Handb Exp Pharmacol; 2009; 187(187):155-86. PubMed ID: 18825340
[TBL] [Abstract][Full Text] [Related]
10. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.
Belvisi MG; Birrell MA; Wortley MA; Maher SA; Satia I; Badri H; Holt K; Round P; McGarvey L; Ford J; Smith JA
Am J Respir Crit Care Med; 2017 Nov; 196(10):1255-1263. PubMed ID: 28650204
[TBL] [Abstract][Full Text] [Related]
11. Irritant-induced chronic cough: irritant-induced TRPpathy.
Brooks SM
Lung; 2008; 186 Suppl 1():S88-93. PubMed ID: 18239961
[TBL] [Abstract][Full Text] [Related]
12. TRPV1 receptors in sensitisation of cough and pain reflexes.
Adcock JJ
Pulm Pharmacol Ther; 2009 Apr; 22(2):65-70. PubMed ID: 19141328
[TBL] [Abstract][Full Text] [Related]
13. Theophylline inhibits the cough reflex through a novel mechanism of action.
Dubuis E; Wortley MA; Grace MS; Maher SA; Adcock JJ; Birrell MA; Belvisi MG
J Allergy Clin Immunol; 2014 Jun; 133(6):1588-98. PubMed ID: 24406072
[TBL] [Abstract][Full Text] [Related]
14. Effect of San'ao decoction with scorpio and bombyx batryticatus on CVA mice model via airway inflammation and regulation of TRPA1/TRPV1/TRPV5 channels.
Wang P; Shang E; Fan X
J Ethnopharmacol; 2021 Jan; 264():113342. PubMed ID: 32890712
[TBL] [Abstract][Full Text] [Related]
15. Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig.
Bolser DC; DeGennaro FC; O'Reilly S; Chapman RW; Kreutner W; Egan RW; Hey JA
Br J Pharmacol; 1994 Dec; 113(4):1344-8. PubMed ID: 7889290
[TBL] [Abstract][Full Text] [Related]
16. Drugs to suppress cough.
Chung KF
Expert Opin Investig Drugs; 2005 Jan; 14(1):19-27. PubMed ID: 15709918
[TBL] [Abstract][Full Text] [Related]
17. Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig.
McLeod RL; Jia Y; Fernandez X; Parra LE; Wang X; Tulshian DB; Kiselgof EJ; Tan Z; Fawzi AB; Smith-Torhan A; Zhang H; Hey JA
Pharmacology; 2004 Jul; 71(3):143-9. PubMed ID: 15161996
[TBL] [Abstract][Full Text] [Related]
18. Antitussive effects of GABAB agonists in the cat and guinea-pig.
Bolser DC; Aziz SM; DeGennaro FC; Kreutner W; Egan RW; Siegel MI; Chapman RW
Br J Pharmacol; 1993 Sep; 110(1):491-5. PubMed ID: 8220912
[TBL] [Abstract][Full Text] [Related]
19. Cough: potential pharmacological developments.
Chung KF
Expert Opin Investig Drugs; 2002 Jul; 11(7):955-63. PubMed ID: 12084006
[TBL] [Abstract][Full Text] [Related]
20. Sensory neural targets for the treatment of cough.
Mazzone SB; McGovern AE
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):955-62. PubMed ID: 17714079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
